Cholera News and Research

Latest Cholera News and Research

iOWH, Center for World Health and Medicine partner to combat childhood diarrhea

The Center for World Health and Medicine at Saint Louis University and the Institute for OneWorld Health have established a joint research agreement to develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5.

4 May 2011

Cote d'Ivoire in need of additional humanitarian assistance, on verge of health crisis, U.N. agency says

Though post-election violence in Cote d'Ivoire has ended, thousands of people remain in need of humanitarian assistance, including health care, education, water, shelter and protection, the U.N. Office for the Coordination of Humanitarian Affairs (OCHA) said in a statement (.pdf) on Wednesday, the U.N. News Centre reports.

30 Apr 2011

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced it has accepted delivery of the world's first integrated optical biosensor for disease diagnosis.

27 Apr 2011

Recent releases in Global Health

When health ministers gather for the World Health Assembly in May they will try to come up with a solution to "a dilemma that has dogged decision-makers for decades - whether and when to destroy the last remaining stocks of the smallpox virus," David Heymann and Emma Ross, both of the Global Health Security Centre at Chatham House, write in an article in The World Today.

25 Apr 2011

Clinton says U.S. will continue to back Haiti's quake recovery after meeting with Haitian President-elect

After meeting with Haitian President-elect Michel Martelly on Wednesday, Secretary of State Hillary Rodham Clinton said the U.S. would back Haiti's efforts to recover from the January 2010 earthquake "all the way," VOA News reports. "Martelly is in Washington for key meetings in advance of his May 14 inauguration," the news service notes (Gollust, 4/20).

22 Apr 2011

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

The world must prepare for more major nuclear accidents, U.N. Secretary-General Ban Ki-moon said on Wednesday at a Kiev conference marking the explosion of a reactor at Ukraine's Chernobyl nuclear reactor 25 years ago, the Associated Press reports.

22 Apr 2011

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

Biomagnetics Diagnostics Corp., (PINK SHEETS: BMGP) a developer of revolutionary diagnostic systems and related technology for detecting HIV, hepatitis, tuberculosis, cholera and malaria, and other innovative technologies, today announced it has now completed a series of payments to Los Alamos National Laboratory (LANL) pursuant to the cooperative research and development agreement (CRADA) executed in 2010 between the two organizations.

21 Apr 2011

WHO team assesses medical situation in Cote d'Ivoire; EU doubles aid pledge

A WHO team has visited the western region of Cote d'Ivoire to assess damage to the medical system and identify ways to improve access to care, following months of violence after the country's presidential election last year, U.N. News Centre reports.

21 Apr 2011

BIOTECH Development Partners provides funds to Biomagnetics

Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced it has begun receiving funds from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

20 Apr 2011

Health situation deteriorates in Cote d'Ivoire as violence continues

Medecins Sans Frontieres on Sunday highlighted its concerns about the health situation in Cote d'Ivoire, Reuters reports.

12 Apr 2011

House subcommittee approves bill calling for report on USAID's efforts to address Haiti's cholera outbreak

The House Foreign Affairs Subcommittee on the Western Hemisphere on Thursday "approved by voice vote a bill (HR 1016) that would require the Obama administration to report to Congress within six months on the handling of U.S. funds for combating a cholera outbreak that occurred after last year's earthquake in Haiti," CQ reports.

2 Apr 2011

Los Alamos National Lab, Biomagnetics to develop and commercialize IOBS system

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced further details in next steps to be taken toward full commercialization of the Company's flagship Integrated Optical Biosensor diagnostic system.

30 Mar 2011

Opinions: Counterfeit medicines; oral rehydration therapy in Bangladesh; increasing access to safe drinking water; attracting R&D for health issues in Latin America

"The Obama administration and Congress should continue efforts to strengthen the safety of America's drug supply and, simultaneously, coordinate a global response to the problem of counterfeit drugs," Thomas Kubic, president & CEO of the Pharmaceutical Security Institute and a former deputy assistant director at the FBI, writes in a post on The Hill's "Congress Blog," where he describes the health risks associated with such drugs.

23 Mar 2011

Experts warn radiation fears are diverting attention from public health threats in Japan

Concerns about radiation leaks from Japan's nuclear plant, which was damaged in the recent earthquake and tsunami, might be "diverting attention from potentially worse threats to public health ... like the cold and disrupted supplies of water," Reuters reports.

18 Mar 2011

Biomagnetics Diagnostics initiates miniaturization process for optical biosensor platform

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory.

16 Mar 2011

Backscattering interferometry can precisely measure membrane protein interactions

A new laser technique has demonstrated that it can measure the interactions between proteins tangled in a cell's membrane and a variety of other biological molecules. These extremely difficult measurements can aid the process of drug discovery.

16 Mar 2011

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

9 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

Scientist develops cryo-electron microscopy to clarify salmonellae structure

Bacteria like salmonellae infect their host cells by needle-shaped extensions which they create in large numbers during an attack. A group of Vienna-based scientists headed by Thomas Marlovits employed recently developed methods of cryo-electron microscopy and have been able to clarify the structure of this infection apparatus on the near-atomic scale.

4 Mar 2011

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.

2 Mar 2011

Cholera News and Research

Latest Cholera News and Research

iOWH, Center for World Health and Medicine partner to combat childhood diarrhea

Cote d'Ivoire in need of additional humanitarian assistance, on verge of health crisis, U.N. agency says

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Recent releases in Global Health

Clinton says U.S. will continue to back Haiti's quake recovery after meeting with Haitian President-elect

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

WHO team assesses medical situation in Cote d'Ivoire; EU doubles aid pledge

BIOTECH Development Partners provides funds to Biomagnetics

Health situation deteriorates in Cote d'Ivoire as violence continues

House subcommittee approves bill calling for report on USAID's efforts to address Haiti's cholera outbreak

Los Alamos National Lab, Biomagnetics to develop and commercialize IOBS system

Opinions: Counterfeit medicines; oral rehydration therapy in Bangladesh; increasing access to safe drinking water; attracting R&D for health issues in Latin America

Experts warn radiation fears are diverting attention from public health threats in Japan

Biomagnetics Diagnostics initiates miniaturization process for optical biosensor platform

Backscattering interferometry can precisely measure membrane protein interactions

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Scientist develops cryo-electron microscopy to clarify salmonellae structure

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Cholera News and Research

Latest Cholera News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in